Financing

A managing director at Advent, Serta’s owner, said that Apollo should have never been allowed to own Serta debt and that at least one executive at the investment giant was aware of that.

The days when a pre-revenue biotech company can raise a lot of money through a public listing are gone for now.

Strategics have more favorable financing lined up compared to PE firms.